A Conservative Blueprint for Universal Healthcare Achieving universal coverage is possible using the ACA as a framework Mar 23, 2023
FDA Panel Supports Tofersen for Rare Genetic ALS In a first, agency advisors back neurofilament light as a surrogate endpoint Mar 23, 2023
Biden Administration Announces Plan to Overhaul the Organ Transplant System Steps include making contracting more competitive and publishing donation data Mar 22, 2023
FDA OKs Another PD-1 Inhibitor for Merkel Cell Carcinoma Retifanlimab produced responses in 52% of patients with untreated unresectable disease Mar 22, 2023
FDA Has Neglected Clinical Trial Transparency — Plus $45 Billion in Fines It's time for more aggressive enforcement of the law Mar 21, 2023
Investigational ALS Drug May Have Clinical Benefit, FDA Staff Says Neurofilament light will be evaluated as a surrogate endpoint in tofersen review Mar 20, 2023
FDA Allows Lower Risk Designation for Snuff Product The brand joins a limited few granted modified risk tobacco claims Mar 16, 2023
More Money, Better Standards Needed to Improve Health Cybersecurity, Senators Told Small rural hospitals especially at risk, witness says Mar 16, 2023
CDC, FDA Heads Fire Back at Ladapo Letter Califf and Walensky say Florida Surgeon General's VAERS analysis is "incorrect, misleading" Mar 13, 2023
A Third of Docs Blame Prior Authorizations for Serious Harm to Patients Four in five say they waste resources, forcing use of ineffective treatments, extra visits Mar 13, 2023
AMA, Surgeon General Propose Ways to Prevent Doctor Burnout Get enough sleep, stop prior authorization, and share your story with colleagues Mar 10, 2023
FDA Panel Endorses New First-Line Lymphoma Regimen POLARIX trial supports a favorable risk-benefit profile for polatuzumab vedotin, ODAC members say Mar 10, 2023
First Bimodal Neuromodulation Device for Tinnitus Gets FDA Nod Ringing ears may get relief with sound and tongue stimulation Mar 08, 2023
Only Drug to Prevent Preterm Birth Set to Leave the Market Decision follows FDA advisory committee recommendation for withdrawal Mar 08, 2023
FDA Not Quite Sold on Polivy in Frontline Large B-Cell Lymphoma Regimen Ahead of ODAC meeting, agency reviewers suggest modest PFS results in POLARIX "raise uncertainty" Mar 07, 2023
FDA Mandate on Acetaminophen-Opioid Combinations Appeared Effective Hospitalizations for liver toxicity declined after FDA limited acetaminophen dose Mar 07, 2023
Stella Immanuel Highest U.S. Prescriber of Ivermectin and HCQ Controversial physician has doled out tens of thousands of scripts for both drugs Mar 02, 2023
Expanding ICD Codes May Aid Rare Disease Patients, Research NCATS explores how best to use diagnostic codes to move field forward Mar 02, 2023
Hopkins' Makary Tells Lawmakers COVID Lab Leak a 'No-Brainer' Other expert witnesses open to other origin theories Mar 01, 2023
First Treatment Approved for Rare Neurodegenerative Disorder Omaveloxolone gets FDA nod for Friedreich's ataxia Mar 01, 2023
Omecamtiv Mecarbil for Heart Failure Turned Down by FDA End of the road for cardiac myosin activator Mar 01, 2023
FDA Issues Import Alert on 'Tranq' Drug Xylazine Drug will be under added scrutiny to make sure it's for "legitimate veterinary use," agency says Feb 28, 2023
Docs Push Ivermectin for Flu; Woody's SNL Intro; Energy Dept. Backs Lab Leak Theory Health news and commentary from around the Web gathered by staff Feb 27, 2023
Disparities in Maternal Mortality? 'We Know Exactly What to Do,' Says Lawmaker Black women are three times more likely to die in childbirth Feb 23, 2023
A Ban on the Abortion Drug Mifepristone Is Looming A Texas lawsuit may be disastrous for effective abortion access and FDA's authority Feb 23, 2023
Over-the-Counter Naloxone Has the Power to Save Lives But removing barriers to access is an essential next step Feb 23, 2023
Third Doctor Arrested for U.S. Capitol Riot; Pediatrician Sues for 'Anti-Male' Bias A weekly roundup of healthcare's encounters with the courts Feb 23, 2023
More Investment in Primary Care Needed, Report Finds Workforce is shrinking as fewer adults report having a regular source of care Feb 22, 2023
Alzheimer's Data Faked? Docs 'Groomed' to Overuse Devices; Orphan Drug Fight This past week in healthcare investigations Feb 22, 2023
FDA Approves First Treatment for Geographic Atrophy Secondary to AMD Pegcetacoplan reduced GA lesion growth by 22% over 24 months versus sham injections Feb 18, 2023
FDA OKs First Therapy for Alpha-Mannosidosis Velmanase alfa approved for treating non-CNS manifestations of progressive, inherited disease Feb 17, 2023
Proposed User Instructions for OTC Narcan Has FDA Concerned In emergency setting, proper use and administration by consumer is "essential," says agency staff Feb 14, 2023
Medicare Advantage Ads in Your Patient Portal? CMS Says They Shouldn't Be There Patient outraged when portal mixed MA sales pitch with doctors' notes Feb 14, 2023
CDC: 'Alarming' Rise in Violence, Hopelessness Among Teen Girls Report shows teen girls are "engulfed in a growing wave of sadness, violence, and trauma" Feb 13, 2023
Simone Gold Accused by California Medical Board Gold's license at stake over "unprofessional conduct" related to Jan. 6 insurrection Feb 13, 2023
The 'Extreme' Story of How Two Game-Changing Cancer Drugs Came to Market New book by former Forbes senior editor pulls back the curtain on drug development Feb 13, 2023
What Happened to the Monoclonal Antibodies for COVID-19? Losing focus on monoclonals means neglecting those who need them most: the immunocompromised Feb 13, 2023 video
FDA Warns on Use of Hospira Drug in Kids Due to 'Unsafe' Aluminum Levels Agency cites risk for aluminum toxicity in infants Feb 10, 2023
FDA Has Concerns on 'Unprecedented' Plan for Dostarlimab in Rectal Cancer Panel will discuss if single-arm trials and proposed endpoints are adequate to support approval Feb 08, 2023
Biden Pledges to Extend Medicare's Solvency for 'At Least Two Decades' Healthcare featured prominently in president's State of the Union address Feb 08, 2023
